Courtesy of Dr. Guillermo Migliaro. The Provisional Stenting technique (PS) consists of sequentially placing a stent in the main branch of the bifurcation and, only when faced with a suboptimal outcome (such as < 3 TIMI flow, flow limiting dissection or high residual stenosis), a second stent in the side branch. Several studies have shown<a href="https://solaci.org/en/2017/02/21/double-kissing-crush-vs-provisional-stenting-at-5-years/" title="Read more" >...</a>
This study evaluated the safety and efficacy of the new drug eluting stents (Medtronic, Santa Rosa, California) to treat de novo coronary lesions. These new polymer free drug filled stents have the potential to improve clinical outcomes and allow a shorter dual antiplatelet therapy. In addition, they have been made with three layers of continuous<a href="https://solaci.org/en/2017/02/21/new-generation-of-des-already-being-tested-so-far-safe/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. Around 5% of patients undergoing coronary angiography present severe left main coronary artery (LMCA) lesions. Myocardial revascularization surgery (MRS) is the preferred method for this group, although there is evidence from different randomized trials demonstrating the safety and efficacy of unprotected LMCA angioplasty, with results similar to those obtained through the traditional strategy.<a href="https://solaci.org/en/2017/01/16/left-main-coronary-artery-angioplasty-vs-surgery-a-large-meta-analysis/" title="Read more" >...</a>
We thank all the speakers of the Chile 2016 Sessions who shared their presentations to contribute to our mission of promoting the dissemination of information from research and clinical practice in Interventional Cardiology. You can read and/or download them below Lluberas, Ricardo. “Role of pharmacovasive therapy in the treatment of IAMcEST. Implications for Latin<a href="https://solaci.org/en/2017/01/07/see-the-presentations-of-the-2016-chile-sessions/" title="Read more" >...</a>
In patients with atrial fibrillation undergoing coronary angioplasty with stents, standard anticoagulation with vitamin K antagonists plus dual antiplatelet therapy with a P2Y12 inhibitor and aspirin reduces the risk of stent thrombosis and stroke, but increases the risk of bleeding. The effectiveness and safety of anticoagulation with rivaroxaban plus one or two antiplatelet agents<a href="https://solaci.org/en/2016/12/26/anticoagulated-patients-with-atrial-fibrillation-undergoing-angioplasty-how-to-treat-them/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. Left main coronary artery disease (LMD), has historically been treated with myocardial revascularization surgery (CABG), but for some years now, and with the development of new drug eluting stents (DES), percutaneous coronary intervention (PCI) has been gathering support in this challenging territory. The study analyzed the SYNTAX and PRECOMBAT<a href="https://solaci.org/en/2016/11/10/more-evidence-for-left-main-pci/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. Left main coronary artery (LMCA) lesions have always been defined as high-risk, with surgery as treatment of choice. Drug-eluting stents (DES) have slowly changed that, but their use still lacks strong supporting evidence. The Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) study<a href="https://solaci.org/en/2016/11/09/left-main-coronary-artery-angioplasty-would-be-non-inferior-to-surgery/" title="Read more" >...</a>
Courtesy of Dr. Agustín Vecchia. The link between operator volume and clinical outcomes has been long and widely debated. After years of discussion, there are promoters and detractors. Currently, interventional cardiology societies all over the world classify centers as “high-volume” or “low-volume” using arbitrary parameters, and require training fellows to perform an also arbitrary number of<a href="https://solaci.org/en/2016/10/25/experienced-operators-50-lower-mortality-rates/" title="Read more" >...</a>
Dr. Marco Antonio Martínez Ríos comes from a family of physicians. “Studying Medicine was the most natural thing in the world for me,” admits Martínez Ríos, who in 1993 became president of the Latin American Group of Interventional Cardiology (Grupo Latinoamericano de Cardiología Intervencionista, GLACI), the seed that would grow to become SOLACI in 1994. <a href="https://solaci.org/en/2016/09/27/martinez-rios-solaci-went-from-a-dream-to-a-world-renowned-society/" title="Read more" >...</a>
Much of the speculation around the way of individualizing dual antiplatelet therapy (DAPT) duration after coronary angioplasty has focused on clinical parameters (e. g., diabetes), but a new study published by the Journal of the American College of Cardiology (JACC) and presented at the last European Society of Cardiology (ESC) Congress warns about anatomical factors as<a href="https://solaci.org/en/2016/09/22/procedural-complexity-affects-decision-making-regarding-dapt-duration/" title="Read more" >...</a>